Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers
<p dir="ltr">Head and Neck Cancer (HNC) is the sixth most common cancer type accounting for approximately 900,000 cases and over 400,000 deaths annually. Heterogeneous malignancies involving the oral nasal cavities, paranasal sinuses, pharynx, larynx, and salivary glands are associat...
محفوظ في:
| المؤلف الرئيسي: | Afsheen Raza (492657) (author) |
|---|---|
| مؤلفون آخرون: | Mehdi Bourouba (377477) (author), Said Dermime (79420) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
حسب: Maysaloun Merhi (4246147)
منشور في: (2018) -
Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
حسب: Queenie Fernandes (14557388)
منشور في: (2018) -
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
حسب: Sarra Mestiri (14557379)
منشور في: (2024) -
Chronotherapy in head and neck cancer: A systematic review and meta‐analysis
حسب: Mohammad Abusamak (10712848)
منشور في: (2024) -
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression
حسب: Afsheen Raza (492657)
منشور في: (2023)